澳洲上月IPO市場規模超香港 逾兩年首見
格隆匯11月1日丨據市場消息,澳洲的首次公開招股(IPO)市場熾熱,10月份IPO交易規模兩年多以來首次超過香港。
10月份,有20家公司透過IPO在澳洲市場集資,總計約35億美元,是自2014年11月以來的單月最高規模。同月,香港只有3宗IPO交易,規模爲7.32億美元,創去年4月以來的單月新低。
由於澳洲開放邊境將有助於商業和經濟回升,加上第四季通常是澳洲IPO市場最繁忙的時間,該國的強勁表現可能會持續。目前,澳洲有幾宗大型交易正在推進中,包括基礎建設服務提供商Ventia Services Group Pt尋求融資高達9億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.